MoCRA: What an Imported Cosmetic Actually Needs

Most MoCRA explainers are written for US manufacturers. If you are a brand importing Korean-made product, the obligations land in a different order and some of them are not yours at all. This article covers it from the importing side: which obligations attach to you, which attach to the factory, and what you actually have to collect before a first shipment.

It is orientation, not a compliance opinion. Every statement here has a primary source at the end, and you should read those rather than take this as the last word.

What MoCRA Changed

Before 2022, cosmetics were the least regulated product category the FDA oversaw. There was no registration requirement, no product listing, no mandatory adverse event reporting and no explicit safety substantiation obligation. Products could be sold without the agency knowing they existed.

The Modernization of Cosmetics Regulation Act changed that. It is the most significant expansion of FDA authority over cosmetics since the Federal Food, Drug, and Cosmetic Act was passed in 1938. The core additions:

• Facility registration — manufacturing and processing facilities register with FDA
• Product listing — each cosmetic product is listed, with its ingredients
• Responsible person — a named entity, with a US address, carrying defined obligations
• Safety substantiation — adequate evidence of safety must be on file
• Adverse event reporting — serious adverse events must be reported and records kept
• Recall authority — the FDA can now order a mandatory recall
• Good manufacturing practice — regulations authorised, with requirements phased in

One thing MoCRA did not change: there is still no pre-market approval for cosmetics. You do not submit a product for clearance and wait. That distinction matters, because "no approval needed" is still true while "no obligations" is now false, and brands regularly conflate the two.

Is Your Product Even a Cosmetic?

Answer this before anything else, because everything downstream depends on it and getting it wrong is the most expensive error in the process.

Classification in the US turns on intended use, not on the label. A product intended to affect the structure or function of the body is a drug under the FD&C Act, whatever it is called and whatever category it occupies in Korea. The FDA's guidance on whether something is a cosmetic, a drug, or both is the reference.

For Korean-made product the categories that most often cross the line:

• Sunscreen. An over-the-counter drug in the US, not a cosmetic. This is the single biggest divergence between Korean and US classification, and MoCRA does not apply to it in the cosmetic sense — a different regime does. See what a Korean product needs for the US market.
• Anti-acne products. An OTC drug category with its own requirements.
• Anti-dandruff shampoo. Same.
• Skin-lightening products making more than an appearance claim.
• Anything positioned around repair, healing or regeneration. The words move the classification even when the formula would have been fine.

If your product is a drug rather than a cosmetic, MoCRA registration and listing are not the path you are on, and reading further will mislead you.

Who Is the Responsible Person

This is the concept importers most often get wrong, so it is worth being precise.

The responsible person is the entity whose name appears on the product label — the manufacturer, packer or distributor named there. It must have a US address, because the label has to give US consumers somewhere to send an adverse event report.

For an imported Korean-made product, the responsible person is almost always the brand owner or the US importer, not the Korean factory. A Korean manufacturer cannot serve as your responsible person. It has no US address and no ability to receive US adverse event reports.

The obligations that attach to the responsible person:

• Ensure the product's safety is adequately substantiated, and keep those records
• Submit and maintain the product listing
• Receive and report serious adverse events, and keep adverse event records
• Ensure labelling complies, including the contact for adverse event reporting

None of these transfer to the factory by contract. You can be supplied with the evidence you need — we supply it — but the obligation sits with the responsible person.

Registration and Listing Are Two Different Things

They are frequently discussed as one step. They are not, and for an importing brand the distinction determines who does what.

Facility registration follows the facility. A facility that manufactures or processes cosmetic products for the US market registers with FDA, and registration is renewed on a defined cycle. For imported product, that is the foreign manufacturing facility. It is the factory's obligation, carried out with information the factory holds.

Product listing follows the product and is submitted by the responsible person. It covers the product identity, the category, the ingredient list and the facility where it is made. Each product is listed; a range of five SKUs is five listings.

The practical consequence: you need your manufacturer's registration number before you can complete your listing. That dependency is the most common cause of a delayed first submission, and it is trivially avoidable by asking for the number early rather than at filing time.

Both steps run through FDA's electronic submission portal, and the agency's registration and listing guidance sets out the data required for each.

What Safety Substantiation Actually Means

MoCRA requires "adequate substantiation of safety" on file. It does not prescribe a single test battery, which brands sometimes read as vagueness and sometimes as licence. It is neither — it means the evidence has to be adequate for your specific product, and what is adequate depends on the formula, the use pattern and the population.

In practice a substantiation file is assembled from:

• Raw material safety data — supplier documentation, established use levels, published assessments where they exist
• Formulation-level reasoning — why this combination at these levels is safe for this use
• Stability data — a product that degrades is not the product you substantiated. See what stability testing actually tells you
• Challenge testing — preservative efficacy over the product's life
• Compatibility data — formula against the pack it ships in
• Any product-level testing the formula's risk profile calls for

The important point about timing: this file is assembled during development, not reconstructed afterwards. Every item on that list is generated as a by-product of doing development properly. A brand that decides to build the file after launch is paying to repeat work that was already done and not collected.

This is where the manufacturer relationship matters most. We supply the manufacturing-side evidence — full quantitative formula, raw material specifications, certificates of analysis, stability and challenge reports, process and facility documentation — through our export and regulatory support. Your responsible person assembles it into the substantiation file and holds it.

Talc, Colour Additives and the Category-Specific Rules

Three product-specific obligations catch brands that assumed MoCRA was one uniform regime.

Talc. MoCRA directed the FDA to establish testing requirements for detecting asbestos in talc-containing cosmetics. If your formula contains talc, settle the testing obligation before production rather than after the container is on the water.

Colour additives. These sit outside MoCRA in their own long-standing regime, and it is stricter than most brands expect. Some colours require FDA batch certification. Some are restricted by application area — a colour permitted on the face may not be permitted near the eye. A colour that is routine in Korean manufacturing is not automatically available to you.

Fragrance allergens. MoCRA directed rulemaking on the labelling of fragrance allergens. Confirm the current requirement before artwork is finalised, because label revisions after printing are among the most avoidable costs in a launch.

Small business exemptions. MoCRA exempts certain small businesses from some GMP, registration and listing requirements — but the exemption does not apply to products that regularly contact the mucus membrane of the eye, products that are injected, products intended for internal use, or products intended to alter appearance for more than 24 hours. Do not assume the exemption applies to your range without checking your specific products against those carve-outs.

A Sequence That Works

Ordering these steps by when they can be done rather than when they are usually thought about removes most of the delay.

1. Confirm classification. Cosmetic or drug. Before formulation, not after.
2. Agree the claim set. Claims determine classification, and rewriting them after artwork is printed is the expensive version. This belongs in the development brief — see how to brief a Korean formulation lab.
3. Identify the responsible person. It has to exist as a legal entity with a US address before the label can be designed, because its name goes on the label.
4. Ask the factory for its registration number. Early. This is a one-line email that routinely delays filings by weeks when it is sent late.
5. Collect substantiation as development proceeds. Specifications, certificates of analysis, stability, challenge, compatibility — each one as it is generated.
6. Finalise labelling. Ingredient declaration, net contents, responsible person contact.
7. Submit the product listing. Once the facility registration number exists and the label is final.
8. Set up adverse event handling. A process and a record system, in place before the first unit sells rather than after the first report arrives.

Steps two through five happen during development. A brand that treats MoCRA as a post-development step converts what should be parallel work into a serial delay.

Frequently Asked Questions

Do we need FDA approval before selling a cosmetic in the US?

No. There is no pre-market approval for cosmetics, and MoCRA did not create one. But that is not the same as no obligations: facilities register, products are listed, safety must be substantiated, a responsible person is named on the label, and serious adverse events must be reported. Colour additives are a separate regime and some of those do require certification.

Can our Korean manufacturer be the responsible person?

No. The responsible person is the entity named on the label and must have a US address so consumers can report adverse events. For imported product that is normally the brand owner or the US importer. The manufacturer supplies documentation; it does not carry the obligation.

Who registers the facility — us or the factory?

The factory. Facility registration follows the facility that manufactures or processes the product, including foreign facilities supplying the US market. Product listing is yours. You will need the factory's registration number to complete your listing, so ask for it at the start of the project rather than at filing.

What counts as adequate safety substantiation?

Evidence adequate for your specific product — there is no single prescribed battery. In practice it is raw material safety data, formulation-level reasoning, stability and challenge testing, and compatibility with the pack, plus any product-level testing the formula calls for. All of it is generated during normal development, which is why collecting it as you go costs nothing and rebuilding it later costs a great deal.

Does MoCRA apply to our sunscreen?

Not in the cosmetic sense. Sunscreen is an over-the-counter drug in the US and sits under a different regime with its own requirements, including a permitted UV filter list that is narrower than Korea's. A Korean SPF product generally cannot be relabelled for the US — plan a separate US version or plan not to sell it there.

We are a small brand. Are we exempt?

Possibly from some requirements, but read the carve-outs before relying on it. The small business exemptions do not apply to products that regularly contact the mucus membrane of the eye, injected products, products for internal use, or products intended to alter appearance for more than 24 hours. Check your specific products rather than your company size.

This page is general information for manufacturing planning. It is not legal or regulatory advice, it has no legal effect, and no rights can be derived from it. Requirements change by market and over time — before acting on anything here, confirm the current position with the authority concerned or with qualified counsel.